ID   BEL5GB
AC   CVCL_E475
SY   BEL5 GB; TER260; TER-260; Ter 260; TER304; TER-304; Ter 304; TER424; TER-424; Ter 424; Terasaki B-cell 260
DR   dbMHC; 48491
DR   ECACC; 96070216
DR   IHW; IHW09320
DR   IPD-IMGT/HLA; 10306
DR   Wikidata; Q54795989
RX   PubMed=29171935;
WW   http://pathology.ucla.edu/workfiles/342cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Irish.
CC   HLA typing: A*02:01:01:01,29:02:01:01; B*44:02:01:01,44:03:01:01; C*05:01:01:02,16:01:01:01; DPB1*02:01:02/02:01:19,04:01:01; DQA1*02:01:01:02,03:03; DQB1*02:02:01,03:01:01; DRB1*04:16,07:01:01; DRB4*01:01:01:01,01:03:01:01 (IPD-IMGT/HLA=10306).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
RX   PubMed=29171935; DOI=10.1111/tan.13184;
RA   Turner T.R., Hayhurst J.D., Hayward D.R., Bultitude W.P., Barker D.J.,
RA   Robinson J., Madrigal J.A., Mayor N.P., Marsh S.G.E.;
RT   "Single molecule real-time DNA sequencing of HLA genes at ultra-high
RT   resolution from 126 international HLA and immunogenetics workshop cell
RT   lines.";
RL   HLA 91:88-101(2018).
//